The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, CSPC Pharmaceutical Group's share price is HK$4.80.
CSPC Pharmaceutical Group's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$2.79. Hence, CSPC Pharmaceutical Group's PS Ratio for today is 1.72.
Good Sign:
CSPC Pharmaceutical Group Ltd stock PS Ratio (=1.66) is close to 3-year low of 1.58
The historical rank and industry rank for CSPC Pharmaceutical Group's PS Ratio or its related term are showing as below:
HKSE:01093'
s PS Ratio Range Over the Past 10 Years
Min: 1.58 Med: 2.36 Max: 10.85
Current: 1.72
During the past 13 years, CSPC Pharmaceutical Group's highest PS Ratio was 10.85. The lowest was 1.58. And the median was 2.36.
HKSE:01093's PS Ratio is ranked better than 58.52% of 974
companies
in the Drug Manufacturers industry
Industry Median: 2.38
vs HKSE:01093: 1.72
CSPC Pharmaceutical Group Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of CSPC Pharmaceutical Group was -1.90% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 11.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 15.30% per year.
During the past 13 years, CSPC Pharmaceutical Group's highest 3-Year average Revenue per Share Growth Rate was 49.30% per year. The lowest was -50.00% per year. And the median was 17.50% per year.
Back to Basics: PS Ratio
CSPC Pharmaceutical Group PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CSPC Pharmaceutical Group's PS Ratio
For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CSPC Pharmaceutical Group's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's PS Ratio distribution charts can be found below:
* The bar in red indicates where CSPC Pharmaceutical Group's PS Ratio falls into.
CSPC Pharmaceutical Group PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
CSPC Pharmaceutical Group's Share Price of today is HK$4.80. CSPC Pharmaceutical Group's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$2.79.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
CSPC Pharmaceutical Group (HKSE:01093) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
CSPC Pharmaceutical Group PS Ratio Related Terms
Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01093 has been successfully added to your 